• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

SMG 1121.71

FDA STAFF MANUAL GUIDES, VOLUME I – ORGANIZATIONS AND FUNCTIONS

FOOD AND DRUG ADMINISTRATION

OFFICE OF GLOBAL REGULATORY OPERATIONS AND POLICY

OFFICE OF REGULATORY AFFAIRS

OFFICE OF POLICY AND RISK MANAGEMENT

DIVISION OF PLANNING EVALUATION AND MANAGEMENT

Effective Date: 08/07/2012

[PDF Version]

1. DIVISION OF PLANNING EVALUATION AND MANAGEMENT (DLLRHA).

A. Coordinates development of overall long-and short-range operational program plans and develops field manpower allocations for their accomplishments.

B. Acts as an advisor on matters of planning, manpower management, and program evaluation.

C. Develops and coordinates the implementation of the annual field operational program plans.  Implements ORA’s manpower utilization program.

D. Analyzes field performance data, evaluates overall field accomplishments in terms of stated goals and resource utilization, and recommends changes in operational program plans and field manpower allocations.

E. Develops planning and evaluation policy and guidance materials, based on Agency policy decisions and program evaluation data, for use by the field in program planning and budgeting.  Guides the field in evaluating their own performance and coordinating field evaluation of programs.

F. Provides management analysis services to the Office of Regulatory Affairs Headquarters and Field.

2. PROGRAM EVALUATION BRANCH (DLLRHA1).

A. Analyzes field performance data, evaluates overall field accomplishments in terms of stated goals and resource utilization.

B. Serves as subject matter experts on the development of information systems related to manpower utilization and data extraction.

3. WORK PLANNING BRANCH (DLLRHA2).

A. Develops and maintains domestic and import workload information. 

B. Coordinates with other Agency components in the development of annual workplans.

4. AUTHORITY AND EFFECTIVE DATE.

The functional statements for this Office were approved by the Commissioner of Food and Drugs on August 7, 2012.

-
-